8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Jan 7, 2019)

Filed January 7, 2019For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on January 7, 2019, to provide preliminary, unaudited financial results and an initial outlook for fiscal year 2019. The company announced that its fourth-quarter 2018 revenue is expected to exceed $331 million, representing significant year-over-year growth of at least 50%. For the full fiscal year 2018, DexCom anticipates total revenue to surpass $1.025 billion, marking an increase of over 42% compared to 2017. Looking ahead, DexCom provided its initial financial guidance for fiscal year 2019, forecasting revenue in the range of $1.175 billion to $1.225 billion. These preliminary results and forward-looking statements were shared in conjunction with a presentation at the J.P. Morgan 37th Annual Healthcare Conference. Investors should note that these figures are preliminary and subject to finalization during the preparation of the company's Form 10-K.

Key Highlights

  • 1Preliminary Q4 2018 revenue expected to exceed $331 million, a ~50% increase year-over-year.
  • 2Full-year 2018 revenue projected to surpass $1.025 billion, a ~42% increase year-over-year.
  • 3Initial fiscal year 2019 revenue guidance provided: $1.175 billion to $1.225 billion.
  • 4These preliminary results were announced in conjunction with the J.P. Morgan Healthcare Conference.
  • 5The company expects continued growth in sensor volumes and international expansion in 2019.
  • 6Results are preliminary and unaudited, subject to finalization in the upcoming 10-K filing.
  • 7Forward-looking statements are included, subject to risks and uncertainties detailed in prior SEC filings.

Frequently Asked Questions

This 8-K filing serves to announce DexCom's preliminary, unaudited revenue results for the fourth quarter and full fiscal year 2018, and to provide an initial financial outlook for fiscal year 2019. This information was presented at the J.P. Morgan Healthcare Conference.

For the fourth quarter of 2018, DexCom expected preliminary revenue to exceed $331 million (at least a 50% increase year-over-year). For the full fiscal year 2018, total preliminary revenue was expected to exceed $1.025 billion (more than a 42% increase year-over-year).

DexCom provided an initial revenue outlook for fiscal year 2019, estimating a range between $1.175 billion and $1.225 billion.

No, the financial results reported in this 8-K are preliminary and unaudited. They are subject to finalization as part of DexCom's preparation of its Annual Report on Form 10-K for the twelve months ended December 31, 2018.